Reconsidering liver biopsies during methotrexate therapy

Journal of the American Academy of Dermatology

Volumn 56, Issue 5, 2007, Pages 893-894

  Henning, Jeffery S ^a,b   Gruson, Lisa M ^a   Strober, Bruce E ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Army Medical Department Center and School   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE;

ALCOHOLISM; DIABETES MELLITUS; LETTER; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER TOXICITY; NONALCOHOLIC FATTY LIVER; OBESITY; PRIORITY JOURNAL; PSORIASIS; RHEUMATOID ARTHRITIS;

BIOPSY; DERMATOLOGIC AGENTS; HEPATITIS, TOXIC; HUMANS; LIVER; METHOTREXATE; PRACTICE GUIDELINES;

EID: 34147175530     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2006.12.005     Document Type: Letter

References (6)

1. Herron M., Hinckly M., Hoffman M.S., Papenfuss J., Hansen C.B., Callis K.P., et al. Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol 141 (2006) 1527-1534
2. Langman G., De la M., Hall P., and Todd G. Role of non-alcoholic steatohepatitis in methotrexate-induced liver injury. J Gastroenterol Hepatol 16 (2001) 1395-1401
3. Zachariae H. Have methotrexate-induced liver fibrosis and cirrhosis become rare?. Dermatology 211 (2005) 307-308
4. Erickson A., Reddy V., Vogelgesang S., and West S. Usefulness of the American College of Rheumatology recommendations for liver biopsy in methotrexate-treated rheumatoid arthritis patients. Arthritis Rheum 38 (1995) 1115-1119
5. Aithal G., Haugk B., Das S., Card T., Burt A.D., and Record C.O. Monitoring methotrexate-induced hepatic fibrosis in patients with psoriasis: are serial liver biopsies justified?. Aliment Pharmacol Ther 19 (2004) 391-399
6. Strober B., and Menon K. Folate supplementation during methotrexate therapy for patients with psoriasis. J Am Acad Dermatol 53 (2005) 652-659